Viatris Goodwill and Intangible Assets 2010-2024 | VTRS

Viatris goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Viatris goodwill and intangible assets for the quarter ending September 30, 2024 were $27.541B, a 12.73% decline year-over-year.
  • Viatris goodwill and intangible assets for 2023 were $29.048B, a 12.06% decline from 2022.
  • Viatris goodwill and intangible assets for 2022 were $33.033B, a 13.63% decline from 2021.
  • Viatris goodwill and intangible assets for 2021 were $38.248B, a 9% decline from 2020.
Viatris Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $29,048
2022 $33,033
2021 $38,248
2020 $42,030
2019 $21,241
2018 $23,412
2017 $25,452
2016 $23,680
2015 $12,602
2014 $6,396
2013 $6,858
2012 $5,740
2011 $6,149
2010 $6,100
2009 $5,716
Viatris Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-09-30 $27,541
2024-06-30 $27,745
2024-03-31 $28,827
2023-12-31 $29,048
2023-09-30 $31,559
2023-06-30 $32,617
2023-03-31 $33,275
2022-12-31 $33,033
2022-09-30 $33,068
2022-06-30 $34,624
2022-03-31 $36,231
2021-12-31 $38,248
2021-09-30 $39,157
2021-06-30 $39,854
2021-03-31 $40,397
2020-12-31 $42,030
2020-09-30 $20,783
2020-06-30 $20,479
2020-03-31 $20,374
2019-12-31 $21,241
2019-09-30 $21,211
2019-06-30 $22,424
2019-03-31 $22,563
2018-12-31 $23,412
2018-09-30 $24,036
2018-06-30 $24,033
2018-03-31 $25,366
2017-12-31 $25,452
2017-09-30 $25,255
2017-06-30 $25,003
2017-03-31 $23,764
2016-12-31 $23,680
2016-09-30 $25,247
2016-06-30 $13,547
2016-03-31 $12,845
2015-12-31 $12,602
2015-09-30 $12,014
2015-06-30 $12,039
2015-03-31 $11,886
2014-12-31 $6,396
2014-09-30 $6,730
2014-06-30 $6,809
2014-03-31 $6,822
2013-12-31 $6,858
2013-09-30 $5,351
2013-06-30 $5,332
2013-03-31 $5,557
2012-12-31 $5,740
2012-09-30 $5,923
2012-06-30 $5,959
2012-03-31 $6,188
2011-12-31 $6,149
2011-09-30 $5,785
2011-06-30 $6,203
2011-03-31 $6,170
2010-12-31 $6,100
2010-09-30 $6,131
2010-06-30 $5,263
2010-03-31 $5,576
2009-12-31 $5,716
2009-09-30 $5,783
2009-06-30 $5,608
2009-03-31 $5,310
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00